Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia
Michael S. Khodadoust(Stanford University), Bin Luo(Stanford University), Bruno C. Medeiros(Stanford University), Ryan C. Johnson(Stanford University), Mark D. Ewalt(Stanford University), A S Schalkwyk(Stanford University), Charles D. Bangs(Stanford University), Athena M. Cherry(Stanford University), Sally Arai(Stanford University), Daniel A. Arber(Stanford University), James L. Zehnder(Stanford University), Jason Gotlib(Stanford Cancer Institute)
Cited by 80Open Access